Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study

NCT00640224 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Ovary Syndrome

Interventions

DRUG: rosiglitazone
DRUG: drospirenone/ethinyl estradiol

Sponsor

Silva Arslanian

Collaborators

[object Object]